Home » Topics » BioWorld

BioWorld
RSS

SYNERGEN STARTS PHASE II TRIALS OF IL-1RA

May 3, 1991

JOURNAL SCAN UNITED BIO CLAIMS BETTER HCV DIAGNOSTIC

May 2, 1991

NEWS BRIEFS IMMUNOMEDICS DEAL WITH BOEHRINGER IS OFF

May 2, 1991

NEORX TO COLLABORATE WITH GENENTECH

May 2, 1991

AMGEN DOUBLES ANNUAL REVENUES

May 2, 1991

BIOTECH COMPANIES GO STRAIGHT FOR IPOS

May 2, 1991

ATHENA LICENSES MS DRUG FROM SANDOZ

May 1, 1991

NEWS BRIEFS

May 1, 1991

JOURNAL SCAN COMMON BACTERIUM LINKED TO STOMACH CANCER

May 1, 1991

ALL QUIET ON THE VENTURE FINANCING FRONT

May 1, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...